Helminthiasis: Clinical Trials

4 trials for Helminthiasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 terminated. 4 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 4
Phase 32Terminated 2

Follow Helminthiasis: new trials by email Literature Review of Helminthiasis trials Research Report on Helminthiasis

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms
Albendazole and Ivermectin fixed dose coformulation, Albendazole - Helminthes; Infestation, Intestinal
Phase 2 / Phase 3TerminatedBarcelona Institute for Global Health10012022-01-202025-09-22
Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-4083 Capsules When Given Alone or In Combination With Albendazole Capsules Moves in The Body of Adult Participants With Onchocerca Volvulus Infection
ABBV-4083, Placebo for ABBV-4083, Albendazole - Onchocerciasis
Phase 2TerminatedAbbVie1532021-05-222024-09-19
Efficacy and Microfilaricidal Kinetics of Imatinib for the Treatment of Loa Loa
Imatinib Mesylate, Placebo - Loiasis
Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)202019-09-162022-06-07
Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)
Acetazolamide, Dexamethasone - Neurocysticercosis
Phase 2 / Phase 3TerminatedUniversidad Peruana Cayetano Heredia42015-12-042025-04-01

Narrower conditions

Loiasis (1)  ·  Neurocysticercosis (1)  ·  Onchocerciasis (1)  ·  Onchocerciasis, Ocular (1)

Broader conditions

Infections (4)  ·  Parasitic Diseases (4)  ·  Filariasis (2)  ·  Nematode Infections (2)  ·  Secernentea Infections (2)  ·  Spirurida Infections (2)  ·  Central Nervous System Diseases (1)  ·  Central Nervous System Helminthiasis (1)  ·  Central Nervous System Infections (1)  ·  Central Nervous System Parasitic Infections (1)  ·  Cestode Infections (1)  ·  Cysticercosis (1)  ·  Eye Diseases (1)  ·  Eye Infections (1)

Interventions

Albendazole (2)  ·  Acetazolamide (1)  ·  Dexamethasone (1)  ·  Imatinib Mesylate (1)  ·  Ivermectin (1)

Sponsors

AbbVie (1)  ·  Barcelona Institute for Global Health (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Universidad Peruana Cayetano Heredia (1)

Countries

Cameroon (1)  ·  Democratic Republic of the Congo (1)  ·  Ethiopia (1)  ·  Kenya (1)  ·  Mozambique (1)  ·  Peru (1)

Top investigators

Elise M O'Connell, M.D. (1)  ·  Hector H. Garcia, MD, PhD (1)  ·  Jose Munoz, MD, PhD (1)

Results publications

PMID 36540062, PMID 39805305